Skip to main content
. Author manuscript; available in PMC: 2022 Mar 10.
Published in final edited form as: Dev Med Child Neurol. 2016 Apr 21;58(11):1139–1145. doi: 10.1111/dmcn.13126

Figure 1.

Figure 1.

For each outcome measure (row) the effect sizes and adjusted responses are shown for statistically significant predictors (columns). Plots are only shown for variables that had a significant relationship in the regression model (see Table II). All measures are dimensionless, except for age (years). Energy cost is expressed as a multiple of energy cost for a speed-matched control (×SMC). The dashed line in the post- vs. pre-treatment plots represents no change. Post-treatment levels above this line are improvement, and below the line are worsening, except for energy cost where below the line represents improvement. For each outcome domain, pre-treatment levels closer to those of typically-developing individuals lead to smaller improvements (or worsening) after treatment. We have described this response as “diminishing returns”. In contrast, higher Walk-DMC values, reflecting control more like that of typically developing individuals, lead to larger postoperative improvements, or “increasing returns”. The pre-treatment level of the outcome variable had the largest effect size across all outcomes. Walk-DMC had the next largest effect size – larger than treatment choice or age - except in the case of energy cost, where Walk-DMC was not a significant predictor. It is also noteworthy that the effect size of treatment choice is consistently small, and in the case of the PODCI-SPF, not statistically significant.